Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.61 |
| ▸ | ACHE | P22303 | 1/20 | 0.61 |
| ▸ | KIF11 | P52732 | 8/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 3/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL29163622 | 0.92 | LMNA (0.58) | LMNATSHRALOX12ACHEKIF11 | |
| Toluene SCHEMBL3861980 | 0.88 | ACHE (0.69) | LMNATSHRALOX12ACHEKIF11 | |
| Toluene SCHEMBL1989071 | 0.87 | TSHR (0.52) | LMNATSHRALOX12ACHEKIF11 | |
| Toluene SCHEMBL21981119 | 0.87 | TSHR (0.52) | LMNATSHRALOX12ACHEKIF11 | |
| Toluene SCHEMBL9480148 | 0.85 | DNM1 (0.52) | LMNATSHRALOX12ACHEKIF11 | |
| Toluene SCHEMBL8519058 | 0.85 | TSHR (0.50) | LMNATSHRALOX12ACHEKIF11 | |
| Dodecylamine SCHEMBL20338081 | 0.84 | DNM1 (0.56) | LMNATSHRALOX12ACHEKIF11 | |
| Toluene SCHEMBL20338086 | 0.84 | DNM1 (0.56) | LMNATSHRALOX12ACHEKIF11 | |
| Toluene SCHEMBL28891446 | 0.84 | DNM1 (0.56) | LMNATSHRALOX12ACHEKIF11 | |
| Toluene SCHEMBL4774666 | 0.82 | ACHE (0.69) | LMNATSHRALOX12ACHEKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2370479-B1 | BROMINATED FLAME RETARDANTS AND PRECURSORS THEREFOR | ALBEMARLE CORP (US) | 2019-03-13 | — | — | EP | disclosed |
| US-8933159-B2 | Brominated flame retardants and precursors therefor | ALBEMARLE CORPORATION (US) | 2015-01-13 | — | — | US | disclosed |
| CN-1847325-B | Dye composition with a reduced content of starting materials and dyeing process | OREAL | 2012-09-05 | — | — | CN | disclosed |
| EP-2370479-A1 | BROMINATED FLAME RETARDANTS AND PRECURSORS THEREFOR | Albemarle Corporation (US) | 2011-10-05 | — | — | EP | disclosed |
| US-20110224353-A1 | Brominated Flame Retardants And Precursors Therefor | ALBEMARLE CORPORATION (US) | 2011-09-15 | — | — | US | disclosed |
| WO-2010065468-A1 | BROMINATED FLAME RETARDANTS AND PRECURSORS THEREFOR | ALBERMARLE CORPORATION (US) | 2010-06-10 | — | — | WO | disclosed |
| EP-1025092-A2 | PREPARATION OF ASYMMETRIC CYCLIC UREAS THROUGH A MONOACYLATED DIAMINE INTERMEDIATE | Du Pont Pharmaceuticals Company (US) | 2000-08-09 | — | — | EP | disclosed |
| US-6077329-A | ADDING SOLUTION OF ALANE-AMINE ADDUCT DISSOLVED IN ORGANIC SOLVENT TO CATALYST-CONTAINING SOLUTION HEATED TO REACTION TEMPERATURE TO DECOMPOSE ALANE INTO ALUMINUM POWDER | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2000-06-20 | — | — | US | disclosed |
| WO-1999018085-A2 | PREPARATION OF ASYMMETRIC CYCLIC UREAS THROUGH A MONOACYLATED DIAMINE INTERMEDIATE | Britol-Myers Squibb Pharma Company (US) | 1999-04-15 | — | — | WO | disclosed |
| US-5885321-A | CATALYTIC DECOMPLEXING AND REDUCTION TO PRECIPITATE ALUMINUM METAL FROM SOLUTION OF COMPLEXED ALUMINUM HYDRIDE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1999-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224353-A1 | Brominated Flame Retardants And Precursors Therefor | BYSL, NOTUM, HADHB | LMNA 1524/4885TSHR 698/4885ALOX12 3031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.